Literature DB >> 8377066

Metoclopramide in anorexia caused by cancer-associated dyspepsia syndrome (CADS).

K A Nelson1, T D Walsh.   

Abstract

Anorexia is a common problem in advanced cancer, part of the cancer anorexia-cachexia syndrome. Although the etiology is multifactorial, symptoms suggestive of gastroparesis are often present in patients with cancer anorexia. We have successfully used metoclopramide, a prokinetic agent, to stimulate appetite in advanced cancer and relieve other dyspeptic symptoms associated with anorexia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8377066

Source DB:  PubMed          Journal:  J Palliat Care        ISSN: 0825-8597            Impact factor:   2.250


  12 in total

Review 1.  Management of gastrointestinal motility disorders. A practical guide to drug selection and appropriate ancillary measures.

Authors:  J R Malagelada; E Distrutti
Journal:  Drugs       Date:  1996-10       Impact factor: 9.546

2.  Suffering and dying in cancer patients. Research frontiers in controlling confusion, cachexia, and dyspnea.

Authors:  N MacDonald
Journal:  West J Med       Date:  1995-09

3.  Gastrointestinal symptoms, electrogastrography, inflammatory markers, and PG-SGA in patients with advanced cancer.

Authors:  Martin Chasen; Ravi Bhargava
Journal:  Support Care Cancer       Date:  2011-06-19       Impact factor: 3.603

Review 4.  Modern management of the cancer anorexia-cachexia syndrome.

Authors:  K A Nelson
Journal:  Curr Oncol Rep       Date:  2000-07       Impact factor: 5.075

5.  An open study of methotrimeprazine in the management of nausea and vomiting in patients with advanced cancer.

Authors:  A Kennett; J Hardy; S Shah; R A'Hern
Journal:  Support Care Cancer       Date:  2005-02-08       Impact factor: 3.603

Review 6.  Anorexia in older persons: epidemiology and optimal treatment.

Authors:  J E Morley
Journal:  Drugs Aging       Date:  1996-02       Impact factor: 3.923

7.  Symptom clustering in advanced cancer.

Authors:  Declan Walsh; Lisa Rybicki
Journal:  Support Care Cancer       Date:  2006-02-16       Impact factor: 3.603

Review 8.  [Cannabinoids in the treatment of the cachexia-anorexia syndrome in palliative care patients].

Authors:  F Nauck; E Klaschik
Journal:  Schmerz       Date:  2004-06       Impact factor: 1.107

Review 9.  Ethical dilemmas in hospice and palliative care.

Authors:  B M Kinzbrunner
Journal:  Support Care Cancer       Date:  1995-01       Impact factor: 3.603

Review 10.  Modern management of the cancer anorexia-cachexia syndrome.

Authors:  K A Nelson
Journal:  Curr Pain Headache Rep       Date:  2001-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.